Back to results
US 2024/0197718 A1Published application
Therapeutic or prophylactic agent for cachexia accompanied by ghrelin resistance
AssigneeToray Industries, Inc.
InventorsMasashi Uchida, Yu Omori
Life of this patent
Estimating the term…
Abstract
There is a problem of providing a therapeutic or prophylactic agent for cachexia accompanied by ghrelin resistance. The therapeutic or prophylactic agent for cachexia accompanied by ghrelin resistance contains, as an active ingredient, an opioid κ receptor agonist compound represented by the formula (I):
Claims7
1-6. (canceled)
A method of treating or preventing cachexia accompanied by ghrelin resistance, the method comprising a step of administering an opioid κ receptor agonistic compound.
Dependencies are inferred from the claim text.